Emma Cooksey narrowly averted a potentially devastating car accident when she dozed off while driving her seven-month-old baby home, a consequence of chronic poor sleep that had troubled her for most of her adult life. After repeated consultations with doctors yielded no answers, Cooksey was eventually diagnosed with sleep apnea, a disorder characterized by recurring pauses in breathing during sleep. Many patients with this condition remain unaware of the interruptions in their breathing, complicating timely diagnosis and treatment.

Sleep apnea is a widespread disorder, affecting approximately one in eight people globally. Beyond causing daytime fatigue and sleepiness, the condition has been linked to serious health risks, including cardiovascular disease, impaired immune function, memory problems, and, more recently, connections to neurodegenerative conditions like Parkinson’s disease. Despite its prevalence, awareness remains low, and the disorder is frequently misdiagnosed or overlooked, particularly in women—partly due to outdated perceptions that sleep apnea primarily affects overweight men.

Cooksey’s experience highlights the challenges patients face. Although her symptoms included excessive daytime sleepiness and disrupted sleep patterns, these were not initially connected to sleep apnea by medical professionals. Her eventual treatment involved positive airway pressure (PAP) therapy, which delivers air through the mouth or nose to keep the airway open during sleep. She describes the intervention as life-saving, although experts caution that PAP therapy does not work for all patients, underscoring the need for additional treatment options.

Researchers emphasize the importance of increased public and scientific attention to sleep apnea due to its significant societal and economic impact. The disorder not only compromises individual health but also contributes to broader burdens such as increased healthcare costs and loss of productivity. However, the development of new therapies is hindered by limited investment from private companies, as the anticipated profits from sleep apnea treatments may not be immediate or substantial.

National funding agencies like the National Institutes of Health play a crucial role in advancing research aimed at understanding and treating sleep apnea. Experts advocate for continued public investment to accelerate the discovery of effective therapies, which could in turn reduce the overall health burden linked to untreated sleep disorders.

In addition to advancing medical interventions, raising awareness among healthcare providers and the public is essential. Improving education about the diverse symptoms and risks associated with sleep apnea could lead to earlier diagnosis and intervention, potentially improving quality of life for millions. Individuals like Cooksey, now active in outreach efforts through organizations such as Project-Sleep.com, hope to shed light on a condition that often remains hidden but carries profound consequences for health and safety.